<DOC>
	<DOC>NCT00922987</DOC>
	<brief_summary>Clinical study with Lyrica (pregabalin) in patients suffering from epilepsy. This drug is used as adjunctive therapy with one or more antiepileptics. Lyrica has potential to reduce seizure frequency.</brief_summary>
	<brief_title>Clinical Study With Lyrica In Patients Suffering From Epilepsy</brief_title>
	<detailed_description>- Included all adult patients with partial seizures and without contraindications according to Summary of Product Characteristics (SmPC).</detailed_description>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Neuralgia</mesh_term>
	<mesh_term>Pregabalin</mesh_term>
	<criteria>Adult patients with partial seizures. Contraindications according to Summary of Product Characteristics (SmPC).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>lyrica pregabalin epilepsy partial seizures</keyword>
</DOC>